Next-Generation Biomanufacturing Market is estimated to be US$ 40.9 billion by 2032; Rising demand for biopharmaceuticals to Fuel Market Growth

Biomanufacturing is the use of biological systems which are engineered and used outside their natural context to develop a product. Next-generation biomanufacturing technologies includes, single-use technologies, automation, continuous development & manufacturing and others.

Growing prevalence of chronic diseases and demand for personalized medicine has become a leading factor in target market growth. Further, emergence of continuous biomanufacturing technologies that offers various benefits such as improved product quality and increased efficiency with reduced cost which has given rise in demand for Next-Generation Biomanufacturing market growth.

The report “Next-Generation Biomanufacturing Market, By Workflow Type (Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow), By Application (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others), By End-Users (Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

 Key Highlights:

• In June 2023, India’s Enzene Biosciences has committed to open around $50 million biomanufacturing plant near Princeton, New Jersey. The new plant will use continuous and latest manufacturing technology by supporting production and development of diverse range of biologics.

Analyst View:

Growing use of data science and analytics in biomanufacturing help in increasing product quality, cost reduction, and improves efficiency of product. Further, rising focus on sustainability in biomanufacturing industries to reduce carbon footprint has driven the development of environment friendly biomanufacturing processes thereby, boosting market growth. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on

“Next-Generation Biomanufacturing Market, By Workflow Type (Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow), By Application (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others), By End-Users (Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Market Insights from the report:

Next-Generation Biomanufacturing Market accounted for US$ 19.9 billion in 2022 and is estimated to be US$ 40.9 billion by 2032 and is anticipated to register a CAGR of 7.8%. The Next-Generation Biomanufacturing Market is segmented based on Workflow Type, Application, End-Users and Region.

• Based on Workflow Type, Next-Generation Biomanufacturing Market is segmented into Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow.
• Based on Application, Next-Generation Biomanufacturing Market is segmented into Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others.
• Based on End-Users, Next-Generation Biomanufacturing Market is segmented into Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others.
• By Region, the Next-Generation Biomanufacturing Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Next-Generation Biomanufacturing Market:

The prominent players operating in the Next-Generation Biomanufacturing Market includes, Merck & Co., Sartorius AG, ESCO Group LLC., Danaher Corporation, Thermo Fisher Scientific Inc., Meissner Filtration Products Inc., PBS Biotech Inc., Solaris Biotechnology Srl., GEA Group AG, bbi-biotech GmbH, and Others.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com